Diabetes and Cirrhosis: What Changes When the Liver Is Scarred

Fatty liver is the liver problem most people with type 2 diabetes hear about, and at that stage the advice runs in a familiar direction — lose some weight, cut liquid sugar, walk. This article is about what happens further along the road, once a liver has actually scarred: cirrhosis, from any cause. Hepatitis C, hepatitis B, years of fatty liver, alcohol — the cause matters for treating the liver, but for blood sugar the scarring itself is what changes things.

And it changes them more than most people expect. Diabetes and cirrhosis are not two conditions running side by side; the second one quietly rewrites how you manage the first. Three things in particular stop behaving the way they used to.

1. Your HbA1c may be reading low

HbA1c works by measuring how much sugar has stuck to your red blood cells over their roughly three-month lifespan. Cirrhosis shortens that lifespan — an enlarged spleen destroys red cells faster, and anaemia is common — so the cells are replaced before they have finished collecting the sugar. The number that comes back is lower than your actual blood sugar warrants.

This is measurable rather than theoretical. In a study published in Digestive Diseases and Sciences (opens in a new tab), HbA1c tracked continuous glucose monitoring data closely in people with diabetes alone (R² 0.94) but poorly in people who had diabetes and cirrhosis together (R² 0.52) — a reassuring HbA1c in that second group simply carried much less information about what glucose was actually doing.

The same shortened-red-cell problem is why diabetes caused by a scarred liver is often missed at diagnosis. Fasting glucose in this situation is frequently normal; the abnormality shows up after eating.

2. Lows become the bigger risk

This is the reversal that catches people out. In ordinary type 2 diabetes, the day-to-day worry is highs. With cirrhosis, hypoglycaemia moves up the list — because the liver is the organ that rescues you from a low.

Two jobs it normally does: it holds a store of glycogen it can release when your sugar drops, and it manufactures fresh glucose when that store runs out. A scarred liver does both badly, and it also clears insulin from the blood less efficiently, so insulin lingers. Add the muscle loss and poor appetite that often come with advanced liver disease and there is very little reserve to fall back on.

So a dose of medicine that was safe for years may not be safe now, and a missed meal costs more than it used to. If you take insulin or a sulfonylurea, this is worth raising with your doctor as soon as cirrhosis is diagnosed rather than after the first bad low.

3. Long gaps without food stop being harmless

A healthy body treats an overnight fast as unremarkable. A cirrhotic body does not — the EASL guidelines on nutrition in chronic liver disease (opens in a new tab) describe accelerated starvation, where the body starts breaking down protein for fuel much sooner than it should. Their recommended pattern is three meals plus three snacks, with the late-evening snack singled out as the most important one because it covers the longest gap of the day, between dinner and breakfast.

For someone managing diabetes that sounds contradictory — eating at bedtime is usually the habit people are trying to break. The guidance for people with both conditions is a low-sugar late-evening snack, not none. Protein is the other surprise: the recommendation is 1.2 to 1.5 g per kg of body weight per day, well above a normal diet, because muscle loss is one of the things that shortens life in cirrhosis. Older advice to restrict protein in liver disease has been reversed for most people.

Voluntary fasting deserves a direct mention here. Ramadan fasting with diabetes already needs a risk assessment; cirrhosis on top of it changes that assessment substantially, and it is a decision to make with your doctor well before Ramadan begins, not in the first week.

What happens to your medicines

The instinct — and sometimes the reflex of a busy clinic — is to stop everything when liver tests look abnormal. That is often the wrong move, metformin in particular. A review of hepatogenous diabetes treatment (opens in a new tab) reports that a meta-analysis found no significant association between metformin and lactic acidosis in this group, and that people who stayed on metformin had a longer median survival than those who did not, alongside a 7% yearly reduction in the risk of primary liver cancer.

Where the medicine list does change is with how much liver function remains. Cirrhosis is graded — Child-Pugh A, B or C — and that grade, not the diagnosis alone, drives most of these decisions.

Why this matters more in Pakistan

Cirrhosis is common here in a way it is not in many countries, largely because hepatitis C is. Diabetes appears in about 30.7% of people with cirrhosis overall, and in 61.2% of those with the most advanced disease, according to the pooled figures in a review of hepatogenous diabetes (opens in a new tab). The practical consequence is that a great many people in Pakistan are managing both conditions — often without anyone having explained that the second one changes the first.

If you have diabetes and have never been tested for hepatitis B and C, that is the single most useful test to ask for, because it is the difference between knowing your liver's situation and guessing at it.

Readings tell the story your HbA1c can't

When HbA1c is unreliable, your own log becomes the primary record — and the pattern to watch for is a normal fasting number with high readings after meals, or lows appearing where they never used to. Logging in Diatic keeps that pattern visible, so you and your doctor are looking at real data rather than one questionable lab value.

Start logging your readings (opens Diatic on Google Play in a new tab)